I have been digging around for therapies to be used in place of SRS for transsexuals who want the cut. The main thing I came up with was CBT, or cognitive behavioral therapy, and ACT or acceptance and commitment therapy. Also, SSRI drugs might be useful **

Name
Email
Subject
Comment *
File	Select/drop/paste files here
* = required field	[▶ Show post options & limits] Confused? See the FAQ.

Embed	(replaces files and can be used instead)
Options	Do not bump (you can also write sage in the email field) Spoiler images (this replaces the thumbnails of your images with question marks)
Password	(For file and post deletion.)
Allowed file types:jpg, jpeg, gif, png, webm, mp4, swf Max filesize is 8 MB. Max image dimensions are 10000 x 10000. You may upload 5 per post.

Anonymous 10/09/15 (Fri) 16:01:45 21f507 No.8702

I have been digging around for therapies to be used in place of SRS for transsexuals who want the cut. The main thing I came up with was CBT, or cognitive behavioral therapy, and ACT or acceptance and commitment therapy. Also, SSRI drugs might be useful and those can be replaced with natural alternatives These work on body dysmorphic disorder, and I will post some findings shortly.

They don't, however, work on body integrity identity disorder, which is a severe disorder where people want to amputate a limb or blind themselves. This disorder is rare, and more extreme to much more extreme than most forms of gender dysphoria.

>BIID patients usually report thinking about their perceived appearance flaws for an average of 3 - 8 hours a day and about one quarter report for more than 8 hours a day (Phillips et al., 2010).

19% of people with BIID also have gender identity issues.

I'll post what I have on this, but there is no clear answer. It probably relates to the severity of the condition. If you feel uncomfortable with your penis on the level of someone with BIID, then probably no therapy that we know of will help. Most transsexuals aren't as extreme as this.

Anonymous 10/09/15 (Fri) 16:03:20 21f507 No.8703

This is for body dysmorphic disorder.

>Body dysmorphic disorder (BDD) is a common mental health problem. People with BDD spend an excessive amount of time thinking about a minor or imagined defect in their physical appearance, and are distressed about it. The usual treatments are cognitive behavioural therapy (CBT), a selective serotonin reuptake inhibitor (SSRI) antidepressant medicine, or both. Treatment often works well to greatly reduce the symptoms and distress.

http://patient.info/health/body-dysmorphic-disorder-leaflet

>Cognitive-behavioral therapy, or CBT, is the first line of treatment for BDD. This type of treatment typically involves a technique known as exposure and response prevention (ERP).

>In BDD, exposure aims to decrease mirror checking, camouflaging, and other compulsive behaviors. It is also intended to prevent behaviors such as avoiding social situations. CBT is effective, but some people with BDD fail to respond. Some improve slightly, and some are unwilling to participate in ERP. For these reasons, it is useful to consider a different approach in conjunction with CBT.

>Acceptance and commitment therapy, or ACT, is one such treatment. ACT focuses on tolerating thoughts and symptoms, rather than trying to change, dispute, and generate alternative interpretations to problems. People with resistant BDD may benefit from ACT because it teaches how to tolerate anxiety-provoking situations.

http://www.adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/body-dysmorphic-disorder-bdd/act-wi

>An open study33 was performed to assess the efficacy of individual CBT in patients with BDD. Seventeen patients diagnosed with DSM-III-R BDD (75% of whom had at least four different types of personality disorder) received 4 weeks of individual intensive CBT, which was carried out five times a week in 90-minute sessions. Sessions were divided into 60 minutes of ERP and 30 minutes of cognitive therapy. At the end of 4 weeks of intensive treatment, the patients showed statistically significant reductions in their initial scores on the Modified Yale Brown Obsessive Compulsive Scale for BDD.

>In another study,34 the authors randomly assigned 19 patients diagnosed with BDD (according to DSM-IV criteria) to individual CBT or to a control waiting list for a period of 12 weeks. The CBT proposed in this study focused on cognitive restructuring (related to perception of body image, beliefs or attitudes related to body image, and attention to self-references) as well as ERP. The control group (10 patients) did not present statistically significant differences on any of the measures evaluated before and after 12 weeks. In contrast, the group of patients that received CBT showed statistically significant improvements on measures of depression (Hospital Depression Score and the Montgomery Asberg Depression Rating Scale) and BDD (YBOCS-BDD and Body Dysmorphic Disorder Examination).

>More recently, Wilhelm et al29 undertook an open study to test a broadly applicable “modular” form of CBT developed specifically to address the unique symptoms of BDD and its associated attributes (involving, eg, skin picking and hair pulling, muscularity and shape, cosmetic treatment, and mood) in a flexible yet structured way. Treatment was delivered in weekly individual sessions over 18 or 22 weeks. Standardized clinician ratings and self-report measures were used to assess BDD (YBOCS-BDD) and related symptoms (Clinical Global Impression, Brown Assessment of Beliefs Scale, Beck Depression Inventory, and Client Satisfaction Inventory) before and after treatment and at 3-month and 6-month follow-up appointments. Following treatment, BDD and associated depressive symptoms showed statistically significant decreases in severity, with 80% of completers considered to be responders (decrease on the YBOCS-BDD initial scores greater than 30%). Treatment gains were maintained at follow-up. Low dropout rates (20%) and very high patient satisfaction ratings (88.9%) suggest that the treatment was highly acceptable to patients.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589080/